| V80302 | |
|
|
|
| 詢價 | |
|
|
|
|
|
|
| 聯系我們 | |
SARS-CoV-2
(Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is
a positive-sense single-stranded RNA virus. Neutralizing antibodies against
SARS-CoV-2 can block the interaction between SARS-CoV-2 RBD and ACE2. It can be
used in the assessment and development of assays for the detection and
quantitation of SARS-CoV-2 neutralizing antibodies. |
| Specificity |
SARS-CoV-2
Spike Protein S1 subunit and its RBD domain |
| Production |
|
|
| Purification |
Affinity
chromatography |
|
| Formulation |
PBS,
pH 7.2, containing 0.02% sodium azide. |
|
| Concentration |
≥ 2 mg/ml |
|
| Clone ID |
R323IgM |
| Target Background |
SARS-CoV-2
(Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is
a positive-sense single-stranded RNA virus. Neutralizing antibodies against
SARS-CoV-2 can block the interaction between SARS-CoV-2 RBD and ACE2. It can be
used in the assessment and development of assays for the detection and
quantitation of SARS-CoV-2 neutralizing antibodies. |
